A detailed break-out of the company’s financial results shows its sports medicine product sales slumped this quarter, sitting at $56.7 million compared to $60.4 million in the same period in 2010. Other product sales, which consist principally of Coblation spine product sales, declined $0.5 million in Q1 of 2011 compared to the same period of 2010.
ArthroCare’s ENT product line, however, experienced a $2.6 million increase in sales.
Read the company news release about ArthroCare’s financial results.
Related Articles on Device Company Financial Results:
Greatbatch Orthopedic Line Sales Increase 34% to $39.6M
Zimmer Posts $1.12B in Q1 Net Sales, 5% Increase
MiMedx Q1 Revenues Up Following Surgical Biologics Acquisition
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.